Understanding urinary conditioning film components on ureteral stents: profiling protein components and evaluating their role in bacterial colonization

Biofouling ◽  
2013 ◽  
Vol 29 (9) ◽  
pp. 1115-1122 ◽  
Author(s):  
Chelsea N. Elwood ◽  
Joey Lo ◽  
Emily Chou ◽  
Adam Crowe ◽  
Olga Arsovska ◽  
...  
1998 ◽  
Vol 160 (3 Part 1) ◽  
pp. 876-881 ◽  
Author(s):  
CHRISTINA TIESZER ◽  
GREGOR REID ◽  
JOHN DENSTEDT

Pathogens ◽  
2020 ◽  
Vol 9 (9) ◽  
pp. 764
Author(s):  
Kymora B Scotland ◽  
Sonia HY Kung ◽  
Ben H Chew ◽  
Dirk Lange

Despite routine implementation in urology, indwelling ureteral stents pose as a nidus for infection. Conditioning film accumulates on stents, which prime pathogen adhesion, promoting infectious biofilm formation. However, the extent to which conditioning film components play a role in facilitating bacterial adhesion and biofilm formation remains largely unknown. Here, we examined the interaction of previously identified stent-bound conditioning film components (fibrinogen, uromodulin, and albumin) with bacterial uropathogens. Cytoscopically removed stents were incubated with common uropathogens (Escherichia coli, Enterococcus faecalis, and Staphylococcus aureus). Immunofluorescent double staining was performed to study the localization of uropathogens relative to stent-bound conditioning film proteins. Conditioning film components were identified on the external stent surface with some deposition in the inner lumen. Bacteria co-localized with fibrinogen, uromodulin, and albumin, suggesting a potential mechanism for stent-associated infections. Here, we determine strong co-localization between common uropathogenic bacterial species with prominent conditioning film components on ureteral stents. Further functional validation of interactions amongst these uropathogens and conditioning film proteins may enhance clinical management for stent-associated infections and development of improved stent technologies.


1999 ◽  
Vol 36 (1) ◽  
pp. 53-59 ◽  
Author(s):  
Claus R. Riedl ◽  
Eugen Plas ◽  
Wilhelm A. Hübner ◽  
Helga Zimmerl ◽  
Walter Ulrich ◽  
...  

2019 ◽  
Vol 30 (5) ◽  
pp. 211
Author(s):  
GedeWirya Kusuma Duarsa ◽  
AnakAgung Gede Oka ◽  
SriRahayu Wulandari ◽  
TjokordaGde Bagus Mahadewa ◽  
Budi Santosa ◽  
...  

Urology ◽  
2011 ◽  
Vol 78 (3) ◽  
pp. S363
Author(s):  
D. Lange ◽  
C. Elwood ◽  
A. Crowe ◽  
R. Miyaoka ◽  
H. Adomat ◽  
...  

1998 ◽  
pp. 876-881 ◽  
Author(s):  
CHRISTINA TIESZER ◽  
GREGOR REID ◽  
JOHN DENSTEDT

BMC Urology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Federico Soria ◽  
Julia E. de La Cruz ◽  
Juan Pablo Caballero-Romeu ◽  
Manuel Pamplona ◽  
Daniel Pérez-Fentes ◽  
...  

Abstract Background Double J ureteral stents are widely used on urological patients to provide drainage of the upper urinary tract. Unfourtunately, ureteral stents are not free from complications, as bacterial colonization and require a second procedure for removal. The purpose of the current comparative experimental study is to evaluate a new heparin-coated biodegradable antireflux ureteral stent (BraidStent®-H) to prevent urinary bacterial colonization. Methods A total of 24 female pigs were underwent determination of bacteriuria and nephrosonographic, endoscopic and contrast fluoroscopy assessment of the urinary tract. Afterward, were randomly assigned animals to Group-I, in which a 5Fr double-pigtail ureteral stent was placed for 6 weeks, or Group-II, in which a BraidStent®-H was placed. Follow-up assessments were performed at 1, 3, 6, 8, 12 weeks. The final follow-up includes the above methods and an exhaustive pathological study of the urinary tract was accomplished after 20 weeks. Results Bacteriuria findings in the first 48 h were significant between groups at 6 h and 12 h. Asymptomatic bacteriuria does not reach 100% of the animals in Group-II until 48 h versus Group-I where it appears at 6 h. The weekly bacteriuria mean rate was 27.7% and 44.4% in Group I and II respectively, without statistical significance. In Group II there were no animals with vesicoureteral reflux, with statistical significance at 3 and 6 weeks with Group-I. The 91.2% of stents in Group-II were degraded between 3 and 6 weeks, without obstructive fragments. Distal ureteral peristalsis was maintained in 66.6–75% in Group-II at 1–6 weeks. Conclusions The heparin coating of BraidStent® allows an early decrease of bacterial colonization, but its effectiveness is low at the long term. Heparin coating did not affect scheduled degradation rate or size of stents fragments. BraidStent®-H avoids the side effects associated with current ureteral stents, thus should cause less discomfort to patients.


2018 ◽  
Vol 10 (1) ◽  
pp. 71 ◽  
Author(s):  
MuhammedA.P. Manzoor ◽  
M Mujeeburahiman ◽  
KS Shabeena ◽  
Rahul Bhargava

1994 ◽  
Vol 21 (8) ◽  
pp. 581-586 ◽  
Author(s):  
Gregor Reid ◽  
Ross Davidson ◽  
John D. Denstedt

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Dirk Lange ◽  
Chelsea N. Elwood ◽  
Adam Crowe ◽  
Ricardo Miyaoka ◽  
Manoj Monga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document